BOULE DIAGNOSTICS AB ORD SWEDEN (OTCMKTS:BDABF) Shorted Shares Increased 500% After Market Selling

January 13, 2018 - By Max Morgan

The stock of BOULE DIAGNOSTICS AB ORD SWEDEN (OTCMKTS:BDABF) registered an increase of 500% in short interest. BDABF’s total short interest was 1,200 shares in January as published by FINRA. Its up 500% from 200 shares, reported previously.

The stock increased 1.84% or $0.6179 during the last trading session, reaching $34.1269. About 2,500 shares traded or Infinity% up from the average. BOULE DIAGNOSTICS (OTCMKTS:BDABF) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

More notable recent BOULE DIAGNOSTICS (OTCMKTS:BDABF) news were published by: Prnewswire.com which released: “The Top 50 Manufacturers of Hematology In-Vitro Diagnostics Analyzers …” on March 27, 2017, also Prnewswire.com with their article: “IRRAS Appoints Fredrik Alpsten as Chief Financial Officer and Deputy CEO” published on August 30, 2017, Bloomberg.com published: “Nordic Tech ‘Miracle’ Delivers 30% Returns for $1 Billion Fund” on February 26, 2017. More interesting news about BOULE DIAGNOSTICS (OTCMKTS:BDABF) were released by: Globenewswire.com and their article: “Hematology Analyzers & Reagents Market – Forecasts to 2019” published on July 30, 2014 as well as Globenewswire.com‘s news article titled: “Global $35.69 Billion Blood Collection, Processing, Management Devices …” with publication date: March 08, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: